BAB V KESIMPULAN DAN SARAN
B. Saran
1. Perlu dilakukan optimasi waktu reaksi dan variasi volume katalis, serta penggunaan katalis oksida logam seperti ZnO agar dapat diperoleh senyawa hasil sintesis dengan rendemen yang lebih besar.
2. Perlu dilakukan uji aktivitas senyawa 9-(4'-hydroxy-3'-methoxyphenyl)- 3,4,5,6,7,9-hexahydro-1H-xanthene-1,8-dione terhadap protein NF-κB secara
DAFTAR PUSTAKA
Atkins, P.W., Jones, dan Loretta, 2010, Chemical Principles: The Quest for Insight,5thedition, W. H. Freeman, New York,p. 459.
Bresnick, S.D., 2004, Intisari Kimia Organik, Penerbit Hipokrates, Jakarta, pp. 96-97, 101-107.
Christy, A. M., 2010, Sintesis Senyawa 2-(4’-klorobenzilidena) sikloheksanadion dari 1,3-Sikloheksanadion dan 4-Klorobenzaldehid dengan Katalis Kalium Hidroksida, Skripsi, Program Sarjana Fakultas Farmasi Universitas Sanata Dharma, Yogyakarta.
Direktorat Jenderal Pengawasan Obat dan Makanan RI, 1995, Farmakope Indonesia, jilid IV, Departemen Kesehatan RI, Jakarta, 1.
Dolcet, X., Llobat, D., Pallares, J., Guiu, X.M., 2005, NF-κB in Development and
Progession of Human Cancer,Virchows Arch, 446 (5): 475-482.
Escárcega RO, Fuentes AS, García CM, Gatica A and Zamora A. 2007. The transcription factor nuclear factor-kB and cancer. Clinical Oncology19 (2): 154–161.
Ettre, L.S., 1993, Nomenclature for chromatography (IUPAC Recommendations 1993),Pure and Appl.Chem., 65 (4): 839-845.
Fessenden, R.J. and Fessenden, J.S., 1994, Kimia Organik, Jilid 2, PenerbitErlangga, Jakarta, pp. 181-183, 455.
Gandjar, I.G., dan Rohman, A., 2007, KimiaFarmasiAnalisis, Pustaka Pelajar, Yogyakarta, pp. 323, 378.
Hanahan D. and Weinberg R.A., 2011. Hallmarks of Cancer : The Next Generation,Cell, 144 (5):646-674.
Hendayana, 2006, Kimia Pemisahan Metode Kromatografi dan Elektroforesis Modern, PT. Remaja Rosdakarya, Bandung, pp. 21-25.
Istyastono, E.P, Yuniarti N., dan Jumina, 2009, Sintesis Senyawa Berpotensi sebagai Inhibitor Angiogenesis: 2-benzilidenasikloheksana-1,3-dion,
Majalah Farmasi Indonesia,20: 1-8.
Jenkins, G. L., Knevel, A. M., Digangi, F. E., 1965,Quantitative Pharmaceutical Chemistry, 6th edition, McGraw-Hill Book Company, New York.
Lee C.H., Jeon Y.T., Kim S.H., and Song Y.S., 2007,NF-kB as a potential molecular target for cancer therapy,BioFactors, 29: 19-35.
Lide, D.R., 2004, Handbook of Chemistry and Physics, 84th edition, CRC Press,pp. 38, 138.
Limanto, K.R., 2013, Desain dan sintesis senyawa 2-(4’-hidroksi-3’- metoksibenzilidena)sikloheksana-1,3-dionyang Berpotensisebagai Senyawa Antikanker dengan Menghambat Protein NF-κB menggunakan Metode Solid Phase Reaction, Skripsi, Program Sarjana Fakultas FarmasiUniversitas Sanata Dharma, Yogyakarta.
Lin, Y., Bai, L., Chen, W., Xu, S., 2010, The NF-κB Activation Pathways, Emerging Molecular Target for Cancer Pervention and Therapy,Expert Opin Ther Targets, 14 (1): 45-55.
MacKenzie, 1967, Experimental Organic Chemistry, 3th Edition, Prentice-Hall, Inc., Englewood Cliffs, New Jersey.
Martin, A., and Bustamante, P., 1993, Physical Pharmacy Chemical Principles in the Pharmaceutical Sciences, 4thEdition, Lea and Febriger, Philadelphia. McMurry, J., 2004, Organic Chemistry, 6th Edition, Brookscole, USA, pp. 822-
825.
NCI, 2013,What is Cancer?, Avaible from URL : http://www.cancer.gov/cancert opics/cancerlibrary/what-is-cancer.html.
Oxtoby, D.W., Gillis, H.P., dan Nachtrieb, N.H., 2001, Prinsip-Prinsip Kimia Modern, 4th, jilid 1, diterjemahkan oleh Akhmadi, Suminar Setiati, Penerbit Erlangga, Jakarta, 439-441.
Palleros D.R., 2004, Solvent-Free Synthesis of Chalcones,J. Chem. Educ.,81(9): 1345-1347.
Reksohadiprodjo, M.S., 1996, Kuliah dan Praktika Kimia Farmasi Preparatif, seri Kimia Fisik Organik, Fakultas Farmasi UGM, Yogyakarta, 7-12. Rowe, R.C., Sheskey, P.J. dan Quinn, M.E., 2009, Handbook of
Pharmaceutical Excipients,6th, Pharmaceuticals Press, London, UK, pp. 760-761.
Sastrohamidjojo, H., 2001,Spektroskopi, edisi kedua, Liberty, Yogyakarta,pp. 47, 71-96, 119-130,163.
Santoso, C.L., 2012, Sintesis Senyawa 2-(4’-hidroksibenzilidena) sikloheksana- 1,3-dion dari Sikloheksana-1,3-dion dan 4-Hidroksibenzaldehid dengan Katalis Kalium Hidroksida, Skripsi, Program Sarjana Fakultas Farmasi Universitas Sanata Dharma, Yogyakarta
Setiawati, M.I., 2012, Sintesis Senyawa 2-(4’-hidroksibenzilidena) sikloheksana- 1,3-dion dari Sikloheksana-1,3-dion dan 4-Hidroksibenzaldehida dengan Katalis Asam Klorida, Skripsi, Program Sarjana Fakultas Farmasi Universitas Sanata Dharma, Yogyakarta.
Silverstein, R.M., Webster, F.X., Kiemle, D., 2005, Spectrometric Identification of Organic Compound, 7thEd., Wiley, New York p. 430.
Skoog, D. A., West, D.M., Holler, F.J., 1994, Analytical Chemistry (An Introduction), 6th ed.,Sounders College Publishers, Philadelphia, 383- 432.
Surh Y.J., 2008,NF-kB and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti- inflammatory and antioxidative activities,Asia Pac J Clin Nutr., 17(51): 269-272.
Tureček, F. dan McLafferty, F.W., 1993, Interpretation of mass spectra,
University Science Books, United Kingdom, p. 290.
Wang, Y.J., Pan, M.H., Cheng, A.L., Lin, L.I., Ho, Y.S., Hsieh, C.Y., Lin, J.K.,1997, Stability of curcumin in buffer solutions and characterization of its degradation products,J Pharm Biomed Anal, 15 (12): 1867-1876. Watson, D.G., 2009, Buku Ajar untuk Mahasiswa Farmasi dan Praktisi Kimia
Farmasi, edisi 2, Winny R. Syarief, Penerbit Buku Kedokteran EGC, Jakarta, 135-136.
Weber W.M., Hunsaker L.A., Roybal C.N., Marjon E.V.B., Abcouwer S.F., Royer R.E., Deck L.M. and Jagt D.L.V., 2006, Activation of NF-kB is inhibited by curcumin and related enones,Bioorganic & Medicinal Chemistry, 14: 2450-2461.
WHO, 2013,Cancer: Fact Sheets,Available from: URL: http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
Willard, H.H., Merritt, L.L., Dean, J.A., Settle, F.A., 1988, Instrumental Method of Analysis, 7thEd., Litton Educational Publishing, USA, p. 422.
Williams, D.H., and Fleming, I., 1997, Spectroscopic Methods in Organic Chemistry, 5thEd., The McGraw-Hill Companies, UK, pp. 173-175.
Wilson, I.D., Plumb, R., Granger, J., Major, H., Williams, R., Lenz, E.M., 2004, HPLC-MS-based Methods for Study of Metabonomics, J. Chromatogr. B, 817 (1): 67-76.
Lampiran 1. Data P S
REPLIKASI I
Berat wadah Berat wadah + zat Berat wadah + sisa Berat zat
Jumlah dalam mmol
4-hid metoksib mula-mula 4,035 m
bereaksi 2,011 m
Sisa 2,024 m
mol produk yang dipe massa produk yang di
LAMPIRAN
ata PenimbanganStarting Materialdan Perhit Senyawa Hasil Sintesis Secara Teoritis
sikloheksana-1,3-dion 4-hidroksi-3-metoksibe 0,204 gram 0,205 gram 0,655 gram 0,819 gram 0,204 gram 0,205 gram 0,451 gram 0,614 gram ol 4,022 mmol 4,035 mmol + 2 hidroksi-3- sibenzaldehida sikloheksana- 1,3-dion me hek 4,035 mmol 4,022 mmol 2,011 mmol 4,022 mmol 2,024 mmol 0 diperoleh = 2,011 mmol
diperoleh secara teoritis = 2,011 mmol x 340,2 = 684,14 mg hitungan Massa sibenzaldehida 9-(4'-hidroksi-3'- metoksifenil)-3,4,5,6,7,9- heksahidro-1H-xanthene- 1,8-dion - 2,011 mmol 2,011 mmol 340,2 mg/ mmol
REPLIKASI II
Berat wadah Berat wadah + zat Berat wadah + sisa Berat zat
Jumlah dalam mmol
4-hid metoksib mula-mula 4,837 m
bereaksi 2,194 m
Sisa 2,643 m
mol produk yang dipe massa produk yang di
sikloheksana-1,3-dion 4-hidroksi-3-metoks 0,417 gram 0,411 gram 0,910 gram 1,154 gram 0,418 gram 0,418 gram 0,492 gram 0,736 gram 4,388 mmol 4,837 mmol + 2 hidroksi-3- sibenzaldehida sikloheksana- 1,3-dion me hek 4,837 mmol 4,388 mmol 2,194 mmol 4,388 mmol 2,643 mmol 0 diperoleh = 2,194 mmol
diperoleh secara teoritis = 2,194 mmol x 340,2 = 746,399 mg oksibenzaldehida 9-(4'-hidroksi-3'- metoksifenil)-3,4,5,6,7,9- heksahidro-1H-xanthene- 1,8-dion - 2,194 mmol 2,194 mmol 340,2 mg/ mmol
REPLIKASI III
Berat wadah Berat wadah + zat Berat wadah + sisa Berat zat
Jumlah dalam mmol
4-hid metoksib mula-mula 3,987 m
bereaksi 1,995 m
Sisa 1,992 m
mol produk yang dipe massa produk yang di
sikloheksana-1,3-dion 4-hidroksi-3-metok 0,412 gram 0,407 gram 1,019 gram 0,858 gram 0,412 gram 0,411 gram 0, 607 gram 0,447 gram ol 3,989 mmol 3,987 mmol + 2 hidroksi-3- sibenzaldehida sikloheksana- 1,3-dion me hek 3,987 mmol 3,989 mmol 1,995 mmol 3,989 mmol 1,992 mmol 0 diperoleh = 1,995 mmol
diperoleh secara teoritis = 1,995 mmol x 340,2 = 678,699 mg toksibenzaldehida 9-(4'-hidroksi-3'- metoksifenil)-3,4,5,6,7,9- heksahidro-1H-xanthene- 1,8-dion - 1,995 mmol 1,995 mmol 340,2 mg/ mmol
Lampiran 2. Data Penimbangan dan PerhitunganRendemenSenyawa Hasil